Plasmonic micro-beads for fluorescence enhanced, multiplexed protein detection with flow cytometry
- 9 June 2014
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 5 (10) , 4070-4075
Abstract
Micro-bead based multiplexed protein immunoassays have experienced rapid growth in the past decade. Thus far, bead based protein assays have relied on the bulky 240 kDa protein phycoerythrin (PE) as the reporter dye to afford a sufficient detection signal and sensitivity, taking advantage of the 25 fluorophores in each protein. Here, we report the synthesis of gold nano-island coated glass beads (4–8 μm) through a two-step seeding-and-growth approach. We developed flow cytometric bead assays with sensitivities as low as 10 fM (∼0.2 pg ml−1) by utilizing the strong fluorescence enhancement of small molecule fluorophores (Cy-5) on the plasmonic gold (pGOLD) beads. By using different fluorescence tags to label the gold beads and varying the bead size, we obtained multiplexed plasmonic gold beads for the quantification of human cytokine IL-6, IFN-gamma, IL-1 beta, VEGF and an ovarian cancer biomarker CA-125 in biologically relevant media. The low limit of detection surpassed those of glass bead based immunoassays by 2 orders of magnitude, demonstrating the potential of plasmonic gold beads for sensitive protein biomarker quantification.Keywords
This publication has 42 references indexed in Scilit:
- Cytokine Levels in the Serum of Healthy SubjectsMediators of Inflammation, 2013
- Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic rangeNature Communications, 2011
- A New Approach to Solution‐Phase Gold Seeding for SERS SubstratesSmall, 2011
- Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem CellsCell, 2009
- Bead-based profiling of tyrosine kinase phosphorylation identifies SRC as a potential target for glioblastoma therapyNature Biotechnology, 2008
- Flow cytometry for drug discovery, receptor pharmacology and high-throughput screeningCurrent Opinion in Pharmacology, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Angiogenesis in life, disease and medicineNature, 2005
- MicroRNA expression profiles classify human cancersNature, 2005